[1] 魏刚, 林双峰, 方永奇, 等. GC-MS 法检测冰片的质量[J]. 中成药, 2005, 27(3): 353-354. [2] 曾池清, 何贵峰. 十批市售冰片的GC-MS分析[J]. 中药材, 2004, 27(5): 347. [3] 国家药典委员会. 中华人民共和国药典[M]. 一部. 北京: 化学工业出版社, 2005: 40. [4] 胡利民, 姜民, 王少峡, 等. 合成冰片对大鼠肝CYP450酶含量及CYP3A1 mRNA 表达的影响[J]. 天津中医药, 2005, 22(4): 284-286. [5] 赵春梅. 冰片单次和多次给药对肝脏微粒体药物代谢酶的影响[D]. 广州: 广州中医药大学, 2002. [6] Sharma A, Pilote S, Bélanger PM, et al.A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study[J]. Br J Clin Pharmacol, 2004, 58(3): 288-297. [7] 陈为烤, 居文政, 许黎君, 等. CYP1A2、CYP2E1和CYP3A4探针间的药动学相互作用[J]. 中药新药与临床药理, 2009, 20(5): 435-438. [8] 刘子修, 刘史佳, 居文政, 等. 黄葵胶囊对大鼠CYP450酶的影响[J]. 中国临床药理学与治疗学, 2010, 15(4): 367-372. [9] 樊慧蓉, 和凡, 刘昌孝. Cocktail探针药物法用于评价细胞色素P450同工酶影响的研究进展[J]. 中国药学杂志, 2006, 41(14): 1045-1048. [10] Brennan BJ, Xu ZX, Grippo J.Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity[J]. Br J Clin Pharmacol, 2013,75(2):497-508. [11] Ardjomand-Woelkart K, Kollroser M, Li L, et al.Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPETM-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma[J]. Anal Bioanal Chem, 2011, 400(8): 2371-2381. [12] Bachmann K, White D, Jauregui L, et al.An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe[J]. J Clin Pharmacol, 2003, 43(10):1082-1090. [13] Sarkar MA, Hunt C, Guzelian PS, et al.Characterization of human liver cytochromes P-450 involved in theophylline metabolism[J]. Drug Metab Dispos, 1992, 20(1): 31-37. [14] Lucas D, Ferrara R, Gonzalez E, et al.Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans[J]. Pharmacogenetics, 1999, 9(3): 377-388. [15] Kharasch ED, Thummel KE, Mhyre J, et al.Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1[J]. Clin Pharmacol Ther, 1993, 53(6):643-650. [16] May DG, Porter J, Wilkinson GR, et al.Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population[J]. Clin Pharmacol Ther, 1994, 55(5): 492-500. [17] Frye RF, Matzke GR, Adedoyin A, et al.Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes[J]. Clin Pharmacol Ther, 1997, 62(4): 365-376. [18] Jurica J, Kyr M, McCaskey Hadasova E, et al. Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration[J]. Neuro Endocrinol Lett, 2009, 30(Suppl 1): 92-95. [19] Wang X, Lee WY, Or PM, et al.Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat[J]. Phytomedicine, 2010, 17(3/4): 203-211. [20] Videau O, Pitarque S, Troncale S, et al.Can a cocktail designed for phenotyping pharmacokinetics and metabolism enzymes in human be used efficiently in rat[J] ? Xenobiotica, 2012, 42(4): 349-354. [21] Wang H, Cheng JD, Montgomery D, et al.Evaluation of the binding orientations of testosterone in the active site of homology models for CYP2C11 and CYP2C13[J]. Biochem Pharmacol, 2009, 78(4): 406-413. [22] 国家药典委员会. 中华人民共和国药典[M]. 一部. 北京: 中国医药科技出版社, 2010: 56. |